Titlebook: Venture Capital and the European Biotechnology Industry; William Bains Book 2009 Palgrave Macmillan, a division of Macmillan Publishers Li

Foment

s fallen behind the US due to under-investment and bad management by the VCs who control the companies.  Detailed analysis shows why it is in VCs‘ interests to damage the very companies they invest in.978-1-349-30381-6978-0-230-22726-2

原谅

Lobotomy

使人入神

Underinvestment in European Biotechnology,Why do new companies fail? We have looked briefly at aspects of management and entrepreneurship, the usual scapegoats for company failure. However, the objective evidence is that overwhelmingly companies fail through undercapitalisation.

CRUDE

VC Management of Companies,Not all businesses require VC investment — indeed, few do, which is a good thing as otherwise hardly any new businesses would be created. ‘Normal’ business is dependent not on start-up capital but on revenue, and specifically on cash reserves built up from profit to buffer revenue fluctuations and provide capital for growth.

deface

What to Do about It: Government,I have reached the point where I am going to try to suggest some solutions to the problems outlined above. As I warned at the start, none of these are complete or enormously compelling. Complex problems rarely have simple, dramatic solutions: they yield to incremental improvement on a number of fronts. This is the approach I advocate.

Adrenaline

Misnomer

BARB

William Bainsw theory. The second aspect has a purely mathematical nature. It is related to the form of factorization (i.e., mathematical description) of hier- chical types 978-94-017-4060-9978-0-306-48062-1Series ISSN 0168-1222 Series E-ISSN 2365-6425

vibrant